US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist

1.830
+0.010+0.55%

Close May 16 16:00 ET

1.900
+0.070+3.83%

Post 19:51 ET

124.45MMarket Cap-1710P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

90.36%-489K

106.63%11.92M

127.27%13.55M

88.00%-5.17M

118.53%8.61M

87.52%-5.07M

-140.47%-179.87M

-75.96%-49.7M

-106.46%-43.08M

-256.11%-46.46M

Net income from continuing operations

-7,652.00%-118.79M

124.84%49.27M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-125.60%-198.38M

-50.66%-42.7M

-132.29%-53.76M

-146.63%-54.07M

Depreciation and amortization

54.41%315K

123.41%1.09M

65.38%301K

83.03%302K

167.62%281K

482.86%204K

836.54%487K

727.27%182K

1,550.00%165K

950.00%105K

Other non cash items

--22K

----

-2,688.76%-2.48M

----

---89K

----

Change In working capital

101.43%164K

-3,901.28%-65.66M

113.65%1.56M

-770.70%-34.06M

-1,241.59%-21.71M

-511.02%-11.45M

-135.71%-1.64M

-926.64%-11.41M

252.15%5.08M

-61.17%1.9M

-Change in receivables

1,092.74%19.82M

-66.82%-24.72M

24.46%-11.04M

2,719.46%4.85M

-137,625.00%-16.53M

-199,500.00%-2M

-10,190.97%-14.82M

-10,053.47%-14.62M

-9,350.00%-185K

---12K

-Change in inventory

30.44%-9.25M

-648.58%-73.13M

-187.65%-26.48M

-2,388.81%-14.01M

---19.33M

---13.3M

---9.77M

---9.21M

---563K

--0

-Change in prepaid assets

27.00%-2.1M

7.74%-4.82M

218.66%2.78M

-634.75%-6.28M

86.86%1.56M

41.06%-2.88M

-16.38%-5.22M

13.96%-2.34M

206.82%1.17M

298.81%837K

-Change in payables and accrued expense

-224.14%-8.43M

34.30%37.48M

146.96%36.59M

-507.45%-18.54M

1,524.29%12.64M

-12.52%6.79M

206.66%27.91M

744.27%14.82M

79.20%4.55M

-85.31%778K

-Change in other current assets

55.28%677K

32.99%1.57M

-43.09%243K

6.22%444K

6.97%445K

631.71%436K

843.20%1.18M

--427K

--418K

1,708.70%416K

-Change in other current liabilities

-10.59%-543K

-122.57%-2.04M

-10.60%-532K

-64.24%-519K

-326.50%-499K

-16,266.67%-491K

---917K

---481K

---316K

---117K

Cash from discontinued investing activities

Operating cash flow

90.36%-489K

106.63%11.92M

127.27%13.55M

88.00%-5.17M

118.53%8.61M

87.52%-5.07M

-140.47%-179.87M

-75.96%-49.7M

-106.46%-43.08M

-256.11%-46.46M

Investing cash flow

Cash flow from continuing investing activities

-98.54%819K

138.52%92.05M

109.17%20.93M

-228.61%-108.09M

2,661.59%123.22M

156.38%55.99M

-414.99%-238.99M

-8,208.74%-228.18M

270.79%84.04M

4.46M

Net PPE purchase and sale

73.20%-67K

50.87%-1.24M

42.58%-356K

22.22%-357K

74.84%-278K

26.90%-250K

-615.58%-2.53M

-233.33%-620K

-200.00%-459K

---1.11M

Net investment purchase and sale

-98.42%886K

139.45%93.29M

109.35%21.28M

-227.49%-107.73M

2,118.43%123.5M

156.83%56.24M

-413.46%-236.46M

-7,685.33%-227.56M

272.26%84.5M

--5.57M

Cash from discontinued investing activities

Investing cash flow

-98.54%819K

138.52%92.05M

109.17%20.93M

-228.61%-108.09M

2,661.59%123.22M

156.38%55.99M

-414.99%-238.99M

-8,208.74%-228.18M

270.79%84.04M

--4.46M

Financing cash flow

Cash flow from continuing financing activities

-87.40%131K

-99.18%3.54M

-99.90%230K

889K

267.15%1.38M

-99.48%1.04M

172.41%431.79M

21,899.25%232.16M

-141.55%-828K

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

----

--0

----

--432.45M

--231.55M

--0

Net preferred stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

-59.14%1.45M

219.51%6.99M

-82.12%347K

--984K

756.45%2.12M

--3.54M

538.19%2.19M

1,238.62%1.94M

--0

8,166.67%248K

Net other financing activities

47.38%-1.32M

-21.22%-3.45M

91.20%-117K

---95K

31.23%-740K

-465.38%-2.5M

-4.17%-2.85M

-14.97%-1.33M

--0

---1.08M

Cash from discontinued financing activities

Financing cash flow

-87.40%131K

-99.18%3.54M

-99.90%230K

--889K

267.15%1.38M

-99.48%1.04M

172.41%431.79M

21,899.25%232.16M

--0

-141.55%-828K

Net cash flow

Beginning cash position

170.25%170.92M

25.54%63.25M

25.38%135.98M

266.17%248.48M

4.02%115.28M

25.54%63.25M

285.58%50.38M

41.09%108.45M

343.99%67.86M

320.80%110.82M

Current changes in cash

-99.11%461K

731.52%107.52M

175.92%34.71M

-374.32%-112.37M

411.05%133.22M

-14.13%51.96M

-65.34%12.93M

-72.54%-45.72M

-33.48%40.96M

-287.44%-42.83M

Effect of exchange rate changes

-246.67%-110K

346.15%160K

-53.25%237K

63.69%-134K

86.67%-18K

210.29%75K

-600.00%-65K

5,533.33%507K

-18,550.00%-369K

-6,850.00%-135K

End cash Position

48.57%171.27M

170.25%170.92M

25.38%135.98M

266.17%248.48M

4.02%115.28M

25.54%63.25M

41.09%108.45M

343.99%67.86M

Free cash flow

89.55%-556K

105.85%10.68M

126.22%13.2M

87.31%-5.53M

117.51%8.33M

87.01%-5.32M

-142.70%-182.4M

-76.99%-50.32M

-107.14%-43.54M

-264.58%-47.57M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	90.36%-489K	106.63%11.92M	127.27%13.55M	88.00%-5.17M	118.53%8.61M	87.52%-5.07M	-140.47%-179.87M	-75.96%-49.7M	-106.46%-43.08M	-256.11%-46.46M
Net income from continuing operations	-7,652.00%-118.79M	124.84%49.27M	111.08%4.73M	138.87%20.89M	140.83%22.07M	103.29%1.57M	-125.60%-198.38M	-50.66%-42.7M	-132.29%-53.76M	-146.63%-54.07M
Depreciation and amortization	54.41%315K	123.41%1.09M	65.38%301K	83.03%302K	167.62%281K	482.86%204K	836.54%487K	727.27%182K	1,550.00%165K	950.00%105K
Other non cash items	--22K	----	----	-2,688.76%-2.48M	----	----	----	----	---89K	----
Change In working capital	101.43%164K	-3,901.28%-65.66M	113.65%1.56M	-770.70%-34.06M	-1,241.59%-21.71M	-511.02%-11.45M	-135.71%-1.64M	-926.64%-11.41M	252.15%5.08M	-61.17%1.9M
-Change in receivables	1,092.74%19.82M	-66.82%-24.72M	24.46%-11.04M	2,719.46%4.85M	-137,625.00%-16.53M	-199,500.00%-2M	-10,190.97%-14.82M	-10,053.47%-14.62M	-9,350.00%-185K	---12K
-Change in inventory	30.44%-9.25M	-648.58%-73.13M	-187.65%-26.48M	-2,388.81%-14.01M	---19.33M	---13.3M	---9.77M	---9.21M	---563K	--0
-Change in prepaid assets	27.00%-2.1M	7.74%-4.82M	218.66%2.78M	-634.75%-6.28M	86.86%1.56M	41.06%-2.88M	-16.38%-5.22M	13.96%-2.34M	206.82%1.17M	298.81%837K
-Change in payables and accrued expense	-224.14%-8.43M	34.30%37.48M	146.96%36.59M	-507.45%-18.54M	1,524.29%12.64M	-12.52%6.79M	206.66%27.91M	744.27%14.82M	79.20%4.55M	-85.31%778K
-Change in other current assets	55.28%677K	32.99%1.57M	-43.09%243K	6.22%444K	6.97%445K	631.71%436K	843.20%1.18M	--427K	--418K	1,708.70%416K
-Change in other current liabilities	-10.59%-543K	-122.57%-2.04M	-10.60%-532K	-64.24%-519K	-326.50%-499K	-16,266.67%-491K	---917K	---481K	---316K	---117K
Cash from discontinued investing activities
Operating cash flow	90.36%-489K	106.63%11.92M	127.27%13.55M	88.00%-5.17M	118.53%8.61M	87.52%-5.07M	-140.47%-179.87M	-75.96%-49.7M	-106.46%-43.08M	-256.11%-46.46M
Investing cash flow
Cash flow from continuing investing activities	-98.54%819K	138.52%92.05M	109.17%20.93M	-228.61%-108.09M	2,661.59%123.22M	156.38%55.99M	-414.99%-238.99M	-8,208.74%-228.18M	270.79%84.04M	4.46M
Net PPE purchase and sale	73.20%-67K	50.87%-1.24M	42.58%-356K	22.22%-357K	74.84%-278K	26.90%-250K	-615.58%-2.53M	-233.33%-620K	-200.00%-459K	---1.11M
Net investment purchase and sale	-98.42%886K	139.45%93.29M	109.35%21.28M	-227.49%-107.73M	2,118.43%123.5M	156.83%56.24M	-413.46%-236.46M	-7,685.33%-227.56M	272.26%84.5M	--5.57M
Cash from discontinued investing activities
Investing cash flow	-98.54%819K	138.52%92.05M	109.17%20.93M	-228.61%-108.09M	2,661.59%123.22M	156.38%55.99M	-414.99%-238.99M	-8,208.74%-228.18M	270.79%84.04M	--4.46M
Financing cash flow
Cash flow from continuing financing activities	-87.40%131K	-99.18%3.54M	-99.90%230K	889K	267.15%1.38M	-99.48%1.04M	172.41%431.79M	21,899.25%232.16M	0	-141.55%-828K
Net issuance payments of debt	----	--0	----	----	----	----	--0	----	----	----
Net common stock issuance	----	--0	--0	--0	----	----	--432.45M	--231.55M	--0	--0
Net preferred stock issuance	----	--0	----	----	----	----	--0	----	----	----
Proceeds from stock option exercised by employees	-59.14%1.45M	219.51%6.99M	-82.12%347K	--984K	756.45%2.12M	--3.54M	538.19%2.19M	1,238.62%1.94M	--0	8,166.67%248K
Net other financing activities	47.38%-1.32M	-21.22%-3.45M	91.20%-117K	---95K	31.23%-740K	-465.38%-2.5M	-4.17%-2.85M	-14.97%-1.33M	--0	---1.08M
Cash from discontinued financing activities
Financing cash flow	-87.40%131K	-99.18%3.54M	-99.90%230K	--889K	267.15%1.38M	-99.48%1.04M	172.41%431.79M	21,899.25%232.16M	--0	-141.55%-828K
Net cash flow
Beginning cash position	170.25%170.92M	25.54%63.25M	25.38%135.98M	266.17%248.48M	4.02%115.28M	25.54%63.25M	285.58%50.38M	41.09%108.45M	343.99%67.86M	320.80%110.82M
Current changes in cash	-99.11%461K	731.52%107.52M	175.92%34.71M	-374.32%-112.37M	411.05%133.22M	-14.13%51.96M	-65.34%12.93M	-72.54%-45.72M	-33.48%40.96M	-287.44%-42.83M
Effect of exchange rate changes	-246.67%-110K	346.15%160K	-53.25%237K	63.69%-134K	86.67%-18K	210.29%75K	-600.00%-65K	5,533.33%507K	-18,550.00%-369K	-6,850.00%-135K
End cash Position	48.57%171.27M	170.25%170.92M	170.25%170.92M	25.38%135.98M	266.17%248.48M	4.02%115.28M	25.54%63.25M	25.54%63.25M	41.09%108.45M	343.99%67.86M
Free cash flow	89.55%-556K	105.85%10.68M	126.22%13.2M	87.31%-5.53M	117.51%8.33M	87.01%-5.32M	-142.70%-182.4M	-76.99%-50.32M	-107.14%-43.54M	-264.58%-47.57M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall